X-ray vision surgery


Augmented reality paves the way for the future of surgery The latest in a series of surgical innovations from product design and development firm Cambridge Consultants is exploring how augmented reality (AR) could transform surgery. The company is showcasing an example of how an augmented surgical system might lower the risk involved in operations – …




Continue reading

Diamond BioPharm Ltd respond to a recent EMA Brexit announcement


On 2nd May 2017 the EMA and European Commission published a notice alerting Marketing Authorisation Holders of centrally authorised medicines of their obligations in relation to Brexit.1 Although the final deal between the UK and the EU is unknown, the notice assumes a complete regulatory break between both parties as of 30th March 2019. According to this notice, …




Continue reading

Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy


Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100% sensitivity Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced it has entered into collaboration with Mayo Clinic, the leading US non-profit medical practice, education, and medical research group. The company’s FAIMS technology is being …




Continue reading

Engineering the future


Tim Fell and Richard Hammond

New partnership set to transform the engineering of biology   Product design and development firm Cambridge Consultants is joining forces with innovative software company Synthace in an ambitious bid to unlock the full potential of biology to address many of the global challenges facing the world. The partnership is aimed at boosting adoption of a …




Continue reading

Aviva Invests in Owlstone Medical Breath Biopsy platform


Investment will drive adoption of new diagnostic modality within healthcare system Cambridge, UK, 27 March 2017: Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc, a global leader in insurance. The investment takes Owlstone Medical’s total funding to $23.5 …




Continue reading

Owlstone Medical Opens New High Volume Breath Biopsy Lab with Tony Blair Visit


New facilities will enable high quality and high throughput Biomarker Services, for identification of novel breath biomarkers in disease diagnostics and precision medicine applications Cambridge, UK, 17 March 2017: Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the …




Continue reading

Cambridge Heartware in the news


Cambridge Heartware is one of the newest companies to move into the Innovation Centre on the Science Park. They are a medical device and algorithm company using artificial intelligence and computer science for the prevention of heart disease and stroke. They are interested in the effect of inherited cardiac disorders as a common cause for electrical disturbances in …




Continue reading